Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of McEwen Mining (NYSE: MUX ) jumped as much as 12% today after the company released production figures.
So what: In the second quarter, the company produced 35,955 gold equivalent ounces, 30% higher than a year earlier. Both of the company's mines are producing at solid levels, and management thinks it can reach 130,000 gold equivalent ounces this year.�
Now what: The strong performance was good, and it didn't hurt that gold itself was up 2.9% today. The low price of gold has hurt miners, so they can use any good news they can get on the pricing front. McEwen hasn't yet posted a profit and, with gold under pressure, I would take a cautious approach to this stock, because even higher production may not make up for falling prices.
Top 10 Low Price Companies To Watch For 2014: First Bancorp Inc(ME)
The First Bancorp, Inc. operates as a holding company for The First, N.A., which is a chartered national bank that provides various banking services to individual and corporate customers in coastal Maine. The company offers various deposit products, including demand, savings, NOW, money market, and certificate of deposit accounts. It also provides various loan products, such as commercial real estate, commercial construction, and other commercial loans; municipal loans; residential term and construction loans; home equity lines of credit; and consumer loans. In addition, the company offers private banking, financial planning, investment management, and trust services to individuals, businesses, non-profit organizations, and municipalities. It operates a network of 14 full-service banking offices in Lincoln, Knox, Hancock, and Washington Counties located in the mid-coast and down east regions of Maine. The company was formerly known as First National Lincoln Corporation and changed its name to The First Bancorp, Inc. in April 2008. The company was founded in 1864 and is based in Damariscotta, Maine.
Top 10 Low Price Companies To Watch For 2014: Cogo Group Inc.(COGO)
Cogo Group, Inc., through its subsidiaries, provides customized module design solutions, focusing on the digital media, telecommunications equipment, and industrial business end-markets in China. In the digital media end-market, the company provides mobile handset and module solutions for functionalities, such as CMMB mobile TV, motion sensor, camera, power supply, and Bluetooth, as well as solutions for high definition digital set-top box, GPS, and solutions for Tablet. In the telecommunications equipment end-market, it offers solutions for public switched telephone network, switching, optical transmitters, electrical signal processing, and optical signal amplification. In the industrial business end-market, the company provides industrial solutions for the smart meter, smart grid, railway, and auto-electronics sectors. In addition, it offers technology and engineering services, network system integration, and related training and maintenance services. Cogo Group, Inc. se lls its customized module design solutions through its direct sales force. The company was formerly known as Comtech Group, Inc. and changed its name to Cogo Group, Inc. in May 2008. The company was founded in 1917 and is based in Shenzhen, China.
Best Stocks To Buy Right Now: Sherritt Intl Corp Com Npv (S.TO)
Sherritt International Corporation, a diversified natural resource company, produces nickel, cobalt, thermal coal, oil and gas, and electricity. The company�s Metals segment engages in mining, processing, and marketing commodity nickel and cobalt; and producing and selling agricultural fertilizers. This segment is also involved in the development of a nickel mine, processing plant, and refinery in Madagascar. Its Coal segment mines and sells thermal coal primarily for use as fuel to generate electricity, as well as holds a portfolio of royalty assets; and leases equipment and operates a contract mine. This segment operates approximately nine surface mines in Alberta and Saskatchewan, Canada. The company�s Oil and Gas segment engages in the exploration and development of oil and gas properties in Cuba, Spain, Pakistan, and the United Kingdom. Its Power segment constructs and operates electricity generating plants that provide electricity in Cuba; and owns an electricity g enerating plant in Madagascar. This segment has a combined generation capacity of approximately 356 megawatts. The company is also involved in mineral products and metallurgical technology business; and licensing its proprietary technologies to mining companies. It has operations primarily in Canada, Cuba, Madagascar, Europe, and Asia. Sherritt International Corporation was founded in 1995 and is headquartered in Toronto, Canada.
Top 10 Low Price Companies To Watch For 2014: Rio Tinto Plc(RIO)
Rio Tinto plc engages in finding, mining, and processing mineral resources. The company produces aluminum products, including bauxite, alumina, and aluminum; copper, gold, molybdenum, silver, and nickel; diamonds; minerals, such as borates, titanium dioxide feedstocks, high purity iron, metal powders, zircon, and rutile; thermal and coking coal, and uranium; and iron ore and salt. It primarily operates in Australia, North America, South America, Asia, Europe, and southern Africa. The company was founded in 1873 and is headquartered in London, the United Kingdom. Rio Tinto plc is a subsidiary of Rio Tinto Group.
Top 10 Low Price Companies To Watch For 2014: Sanmina-SCI Corporation(SANM)
Sanmina-SCI Corporation provides integrated electronics manufacturing services worldwide. It offers product design and engineering services, including initial development, detailed design, prototyping, validation, preproduction, and manufacturing design; volume manufacturing of complete systems, components, and subassemblies; final system assembly and testing services; direct order fulfillment and logistics services; and after-market product service and support services. The company also manufactures various system components and subassemblies consisting of printed circuit boards, printed circuit board assemblies, backplanes and backplane assemblies, enclosures, cable assemblies, precision machine components, optical components and modules, and memory modules. It provides its services to original equipment manufacturers primarily in the communication, enterprise computing and storage, multimedia, industrial and semiconductor capital equipment, defense and aerospace, medica l, clean technology, and automotive industries. The company was founded in 1980 and is based in San Jose, California.
Advisors' Opinion:- [By Sam Collins]
Sanmina-SCI Corporation (NASDAQ: SANM ) is independent global provider of customized, integrated electronics manufacturing services. The stock has been in an intermediate downtrend since April, but recent accumulation and a host of buy recommendations from more than 20 analysts puts this stock back in the spotlight.
SANM recently crossed over its 50-day moving average, and its stochastic flashed a buy. Since it is technically still in a downtrend, stop-loss orders at $10 should be entered. The average target of the fundamental analysts is $24, and S&P rates the stock a "five-star buy" with a 12-month target of $20.
Top 10 Low Price Companies To Watch For 2014: RF Micro Devices Inc.(RFMD)
RF Micro Devices, Inc. designs, develops, manufactures, and markets radio frequency (RF) components and compound semiconductor technologies in the United States and internationally. Its products enable mobility, as well as provide connectivity and support functionality in the cellular handsets, wireless infrastructure, wireless local area networks, cable television /broadband, Smart Energy/advanced metering infrastructure, and aerospace and defense markets. The company offers products that range from single-function components to highly integrated circuits and multi-chip modules (MCMs). Its integrated circuit products include gain blocks, low noise amplifiers, power amplifiers (PAs), receivers, transmitters, transceivers, modulators, demodulators, attenuators, switches, frequency synthesizers, and voltage-controlled oscillators (VCOs); MCM products consist of PA modules, switch-filter modules, active antenna products, VCOs, phase-locked loops, coaxial resonator oscillators , active mixers, variable gain amplifiers, hybrid amplifiers, power doublers, and optical receivers; and passive components consist of splitters, couplers, mixers, and transformers, as well as isolators and circulators. The company markets its products to original equipment manufacturers and original design manufacturers. RF Micro Devices, Inc. was founded in 1991 and is headquartered in Greensboro, North Carolina.
Top 10 Low Price Companies To Watch For 2014: PrimeEnergy Corporation(PNRG)
PrimeEnergy Corporation, through its subsidiaries, engages in the acquisition, exploration, development, and production of crude oil and natural gas in the United States. Its principal properties are located in Texas, Oklahoma, West Virginia, the Gulf of Mexico, New Mexico, Colorado, and Louisiana. The company operates 1,600 oil and gas wells, as well as owns non-operating interests in approximately 800 additional wells. It also provides well-servicing support operations, site-preparation, and construction services for oil and gas drilling and reworking operations, as well as contract services for third parties. In addition, the company involves in the acquisition of producing oil and gas properties through joint ventures with industry partners. As of December 31, 2010, it had proved reserves of 101 billion cubic feet of gas equivalent. The company was founded in 1973 and is based in Stamford, Connecticut.
Top 10 Low Price Companies To Watch For 2014: Uravan Minerals Inc. (UVN.V)
Uravan Minerals, Inc., a development stage mineral exploration company, engages in the acquisition, exploration, and development of mineral properties in Canada. The company primarily explores for buried uranium deposits, as well as for rare earth elements, and nickel-copper-platinum group element deposits in under-explored areas. Its principal properties include the Outer Ring/Math, Johannsen, Halliday, Stewardson, Thluicho, and Poplar Point uranium projects located in the Athabasca Basin, northern Saskatchewan; the Garry Lake uranium project situated in the northeast Thelon Basin; and the Rottenstone nickel-copper-platinum group element property located in Saskatchewan. Uravan Minerals, Inc. is headquartered in Calgary, Canada.
Top 10 Low Price Companies To Watch For 2014: Sarepta Therapeutics Inc (SRPT.W)
Sarepta Therapeutics Inc., formerly AVI BioPharma, Inc., incorporated on July 22, 1980, biopharmaceutical company focused on the discovery and development of ribonucleic acid (RNA)-based therapeutics for the treatment of rare and infectious diseases. The Company�� product candidates include Eteplirsen, AVI-6002, AVI-6003, and AVI-7100. As of December 31, 2011, the Company primarily focused on advancing the development of its Duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen, which is in a Phase IIb trial. The Company is also focused on developing therapeutics for the treatment of infectious diseases, including its lead infectious disease programs aimed at the development of drug candidates for the Ebola and Marburg hemorrhagic fever viruses. The Company's program focuses on the development of disease-modifying therapeutic candidates for Duchenne muscular dystrophy (DMD). The Company initiated a Phase IIb trial for eteplirsen in August 2011 with an objective of initiating a pivotal trial subsequent to 2011.
The Company is also leveraging the capabilities of its RNA-based technology platforms to develop therapeutics for the treatment of infectious diseases. The Company's RNA-based drug programs are clinically evaluated for the treatment of DMD and have also demonstrated anti-viral activity in infectious diseases such as Ebola, Marburg and H1N1 influenza in certain animal models. The Company's lead product candidates are at various stages of development.
Duchenne Muscular Dystrophy Program
The Company's lead program is designed to address specific gene mutations that result in DMD by forcing the genetic machinery to skip over an adjacent contiguous piece of RNA and, thus, restore the ability of the cell to express a new, truncated but functional, dystrophin protein.
Eteplirsen is an antisense PMO-based therapeutic in clinical development for the treat ment of individuals with DMD who have an error in the gene ! c! oding for dystrophin that can be treated by skipping exon 51. Eteplirsen targets the frequent series of mutations that cause DMD. Eteplirsen has been granted orphan drug designation in the United States and European Union. In addition to the Company's lead product candidate, eteplirsen, the Company is actively pursues development of a product candidate that skips exon 45 through an IND-enabling collaboration.
Anti-Viral Programs
The Company is implementing its RNA-based technology platforms in its anti-viral programs for the development of therapeutics to treat viruses, such as Ebola, Marburg and influenza. The Company's arrangement with DoD supporting the development of the Company's Ebola and Marburg virus drug candidates provides funding for all clinical and licensure activities necessary to obtain approval of a New Drug Application (NDA), by the United States Food and Drug Administration (FDA), if DoD exercises all of its options under the arra ngement. During the year ended December 31, 2011, the Company paused its clinical development efforts on AVI-7100 and is exploring funding opportunities or partnerships with DHHS and industry collaborators to advance its development.
The Company's anti-viral therapeutic programs use the Company's translation suppression technology and applies its PMOplus chemistry backbone, an advanced generation of its base PMO chemistry backbone that selectively introduces positive backbone charges to improve selective interaction between the drug and its target. The Company's translation suppressing technology is based on Translation Suppressing Oligomers (TSOs), which are PMO-based compounds that stop or suppress the translation of a specific protein by binding to their specific target sequence in mRNA.
The Company is pursuing development and regulatory approval of its Ebola and Marburg hemorrhagic fever virus product candidates under the FDA's Animal Rule. The Company's lead product candidate against the Ebola viru! s in! fec! tion i! s AVI-6002. For Marburg virus infection, the Company's lead product candidate has been AVI-6003. In February 2012, the Company announced that the Company received approval from the FDA to remove one of the two oligomers composing AVI-6003 and proceed with a single oligomer approach, AVI-7288, given that efficacy in non-human primates has been demonstrated to be attributable to this single oligomer. The Company is exploring the feasibility of alternate routes of administration of its Ebola and Marburg drug candidates, and at DoD's invitation, the Company is developing a proposal to be submitted for a study to demonstrates feasibility of the intramuscular route.
AVI-6002, which is a combination of AVI-7537 and AVI-7539, is designed for post-exposure prophylaxis after documented or suspected exposure to the Ebola virus. The Company is evaluating the feasibility of developing AVI-7537 as a single agent for the post-exposure prophylaxis after documented or suspected exposure to Ebola virus. AVI-6003, which is a combination of AVI-7287 and AVI-7288, is designed for post-exposure prophylaxis after documented or suspected exposure to Marburg virus. In February 2012, the Company announced that the Company received approval from the FDA to proceed with AVI-7288 as a single agent against Marburg virus infection. The Company intends to proceed with dosing AVI-7288 in the Phase I multiple ascending dose studies and in non-human primate studies.
Influenza Program
The Company's anti-viral therapeutic programs are also focused on the development of the Company's product candidates designed to treat pandemic influenza viruses. AVI-7100 is the Company's lead product candidate for the treatment of influenza and employs its PMOplus technology. In June 2011, the Company initiated dosing of AVI-7100 through intravenous infusion in single-ascending doses in up to 48 healthy adult volunteers. As of December 31, 2011, the Company paused its clinical development efforts on AVI-7100 ! and are !! exploring! funding opportunities or partnerships to advance its development.
The Company has developed three new phosphorodiamidate-linked morpholino oligomers (PMO)-based chemistry platforms in addition to its original PMO-based technology. The Company's PMO-based molecules are designed to sterically block the access of cellular machinery to pre-mRNA and mRNA without degrading the RNA. Through this selective targeting, two distinct biologic mechanisms of action can be initiated: modulation of pre-mRNA splicing and inhibition of mRNA translation.
The Company competes with GlaxoSmithKline plc, Toyama Chemical, Alnylam Pharmaceuticals, Inc., Tekmira Pharmaceuticals Corp., Isis Pharmaceuticals, Inc., Prosensa, and Santaris Pharma A/S.
Top 10 Low Price Companies To Watch For 2014: Iris Biotechnologies(IRSB.OB)
Iris BioTechnologies Inc., a development stage life science company, focuses on developing solutions for the detection and monitoring of monogenic and complex genomic diseases. The company provides a Nano-BioChip gene expression kit using a convergence of scientific disciplines in nanotechnology, semiconductor manufacturing, microfluidics, chemistry, molecular biology, genetics, genomics, and information technology; and BioWindows artificial intelligence system, a database comprising data fields for patient demographics information, personal and family medical history, and gene expression information. Its products assist in establishing the foundation for personalized medicine for the treatment of breast cancer. The company also intends to use its product platform to diagnose and treat patients with neurological disorders, heart disease, diabetes, and other gene-related metabolic problems. In addition, it is working on gene markers for CancerChip and specific markers assoc iated with prostrate, lung, liver, kidney, and ovarian cancers, as well as genes associated with schizophrenia, Alzheimer disease, autoimmune system disorders, and metabolic and drug metabolism disorders. The company was founded in 1999 and is headquartered in Santa Clara, California.
No comments:
Post a Comment